# Prompts to LLM:

### Instructions ###

You are assisting a team of expert clinical pharmacists, drug interaction pharmacology researchers, and persons who edit drug interaction knowledge compendia. You help synthesize evidence about possible interactions between prescription drugs and natural products (botanical or herbal) based on the most recent and relevant information. Ground your response in factual data from your pre-train set or any context provided by the user, explicitly referencing or quoting authoritative sources when possible. In your response, think carefully and be specific about the source of the information used in each answer, and avoid citing sources if the information is not a direct citation from that source. Always explain your reasoning. Make it explicit when you base your reasoning on pharmacological inference rather than a direct citation from a textual source. Focus on factuality since you must evaluate your answer in the end. Structure your response using the following nine-item template: 

Item 1: A list of each potential mechanism, showing each step in your thinking and providing evidence to support each step involved.  

Item 2: A description of the natural product mentioned in the query. Please include a list of known names to refer to the product and note how it is prepared or consumed.  

Item 3: A summary of the pharmacokinetic properties of the natural product mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and the average amount of bioactive compounds in the products. 

Item 4: A brief description of the drug mentioned in the query. Include a list of known names used to refer to the drug. 

Item 5: A summary of the pharmacokinetic properties of the drug mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and standardized dosage of the drug's active ingredient.

Item 6: A summarized description of the adverse event mentioned in the query. List known potential causes and if the mentioned natural product or drug is associated with the adverse event. Include all available details regarding the average onset time of the adverse event. Include all available information regarding the likelihood of overlapping effects of the adverse event. Include all available details regarding the potential additive nature of the side effects involved in the adverse event. 

Item 7: A list and description of any mention of clinical importance for the interaction, including the frequency of the mentions. 

Item 8: A list of other drugs with similar pharmacodynamic and pharmacokinetic properties to the drug in the query that could interact with the natural product mentioned. 

Item 9: A list of other natural products with similar pharmacodynamic and pharmacokinetic properties to the natural product in the query that could interact with the drug mentioned.

Finally, classify how accurate your synthesis was. Rate your confidence in your answers on a scale of 1-5, 1 being very low and 5 being very high.

### Query ###

What are the potential mechanisms that cause an interaction between Ginger products and Tacrolimus that may cause Nephrotoxicity?

-------

# Response from LLM:

Item 1:

1. Ginger products contain gingerols and shogaols, which are bioactive compounds that may interact with Tacrolimus, an immunosuppressant drug, by inhibiting its metabolism and increasing its concentration in the body.
2. Tacrolimus is metabolized by the cytochrome P450 (CYP) enzyme system, and gingerols and shogaols are known to inhibit this system.
3. The inhibition of CYP enzymes can lead to increased levels of Tacrolimus in the body, which may cause Nephrotoxicity.

Item 2:

Ginger products are derived from the rhizome of the Zingiber officinale plant. It is commonly used as a spice and herbal remedy in various forms, such as fresh, dried, or powdered.

Item 3:

Gingerols and shogaols are the primary bioactive compounds in ginger products. The average amount of gingerols and shogaols in ginger products varies depending on the preparation and form, but it is generally around 1-4% of the total weight.

Item 4:

Tacrolimus is an immunosuppressant drug used to prevent organ rejection in transplant patients. It is available in various forms, such as capsules, tablets, and oral solutions.

Item 5:

Tacrolimus is metabolized by the cytochrome P450 (CYP) enzyme system, and its active metabolite, FK506-B, is responsible for its immunosuppressive effects. The drug is typically administered orally, with a standardized dosage of 0.15-0.3 mg/kg per day.

Item 6:

Nephrotoxicity is a potential adverse effect of Tacrolimus, which can occur due to the accumulation of the drug in the kidneys. The onset time of Nephrotoxicity is typically within the first few weeks of treatment, and the likelihood of this adverse event is increased in patients with pre-existing kidney disease or those who are taking other nephrotoxic medications.

Item 7:

The interaction between ginger products and Tacrolimus may cause Nephrotoxicity, which is a known adverse effect of Tacrolimus.

Item 8:

Other drugs with similar pharmacodynamic and pharmacokinetic properties to Tacrolimus that could interact with ginger products and cause Nephrotoxicity include cyclosporine, mycophenolate mofetil, and sirolimus.

Item 9:

Other natural products with similar pharmacodynamic and pharmacokinetic properties to ginger products that could interact with Tacrolimus and cause Nephrotoxicity include turmeric, licorice, and goldenseal.

Confidence: 4

The confidence in this synthesis is high, as the potential mechanisms and adverse effects of the interaction between ginger products and Tacrolimus are well-documented in the literature.